Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 452.20 M

Chemed Corporation EBITDA is USD 452.20 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 8.97% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 414.97 M, a 8.95% change year over year.
  • Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 380.88 M, a -8.66% change year over year.
  • Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 417.00 M, a -12.02% change year over year.
  • Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 473.97 M, a 42.34% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)